Price movement over the last 24 hours
AdaptHealth Corp vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF — how do they compare? AdaptHealth Corp trades at $10.08 (market cap $1.38B), while State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.91. The key difference: AdaptHealth Corp is trading nearer its 52-week high, State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF nearer its low. Which is the better fit depends on your goals.
| AHCO | SJNK | |
|---|---|---|
Market Cap | $1.38B | — |
Sector | Health | Sector/Thematic |
52-Week High | $13.38 | $25.63 |
52-Week Low | $8.68 | $24.75 |
Enterprise Value | $3.33B | — |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
SJNK trades at $24.97, up 0.16% on the day, with a bearish technical signal from moving averages and neutral oscillators. The ETF maintains a consistent dividend schedule, with recent payouts of $0.14 and $0.15 per share. Recent news highlights institutional accumulation by firms like Berkshire Money Management, though analyst sentiment remains cautious due to high-yield bond market risks.
The outlook for SJNK is clouded by bearish technical indicators and concerns over the sustainability of high-yield bond performance. Risks include interest rate sensitivity and credit spread volatility, but steady dividends and institutional interest offer some support. Investors should weigh income stability against potential capital depreciation in a tightening credit environment.
Trailing returns across standard periods
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.
Read more on SJNK →